Role of HIF Signaling on Tumorigenesis in Response to Chronic Low-Dose Arsenic Administration
Open Access
- 11 May 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 86 (2), 248-257
- https://doi.org/10.1093/toxsci/kfi190
Abstract
Trivalent inorganic arsenic (arsenite, arsenic trioxide, As(III)) is a primary contaminant of groundwater supplies worldwide. As(III), marketed as trisenox, is also an FDA-approved agent to treat cancer It has been previously shown by our laboratory that As(III) administered at doses lower than a therapeutic anticancer dose results in an increase in tumor formation and blood vessel density of tumors. In this work it was found that chronic administration of As(III) approaching the EPA action level of 10 ppb, given in the drinking water of mice 5 weeks prior to B16-F10 melanoma implantation, increased the growth rate of primary tumors and the number of metastases to the lung. Further, levels of arsenic in the tumor and lung were found to be much greater than those in the blood and similar to pro-angiogenic As(III) doses. Levels of hypoxia inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) surrounding the blood vessels in the tumors of the As(III)-treated mice were also found to be increased. Exposure of isolated B16-F10 tumor cells to chronic (3 or 7 day) but not acute (4 h) low-dose As(III) was found to increase HIF-1α expression and secretion of VEGF. Finally, coadministration of an inhibitor of HIF (YC-1) or a VEGFR-2 kinase inhibitor (SU5416) was found to antagonize the pro-angiogenic effects of low-dose As(III). Together, these results suggest that chronic exposure to low-dose As(III) could stimulate growth of tumors through a HIF-dependent stimulation of angiogenesis.Keywords
This publication has 39 references indexed in Scilit:
- Molecular mechanisms of tumor vascularizationCritical Reviews in Oncology/Hematology, 2005
- HIFs, Hypoxia, and Vascular DevelopmentCurrent Topics in Developmental Biology, 2004
- Oxygen-Dependent and -Independent Regulation of HIF-1alphaJournal of Korean Medical Science, 2002
- Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1α Protein by the Oxidative Stressor ArsenitePublished by Elsevier BV ,2001
- Nickel requires hypoxia-inducible factor-1α, not redox signaling, to induce plasminogen activator inhibitor-1American Journal of Physiology-Lung Cellular and Molecular Physiology, 2001
- Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cellsBiochemical Pharmacology, 2001
- Cervical lymph node metastasis: Model for study of head/neck melanomaOral Oncology, 1995
- 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.Proceedings of the National Academy of Sciences, 1994
- HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell LineJournal of Investigative Dermatology, 1992
- [31] Secreted placental alkaline phosphatase as a eukaryotic reporter geneMethods in enzymology, 1992